• Molecular NamePargyline
  • SynonymBenzyl-methyl-2-propinylamin; Methylbenzylpropynylamine; Methylbenzylpropynylamine hydrochloride; N-Benzyl-N-methyl-2-propyn-1-amine; N-Benzyl-N-methyl-2-propynylamine; N-Benzyl-N-methyl-2-propynylamine hydrochloride; N-Methyl-N-2-propynylbenzylamine; Paragyline; Pargylamine; Pargylin; Pargyline chloride; Pargyline hydrochloride
  • Weight159.232
  • Drugbank_IDDB01626
  • ACS_NO555-57-7
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)2.15
  • pkaN/A
  • LogD (pH=7, predicted)2.03
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.76
  • LogSw (predicted, AB/LogsW2.0)8.9
  • Sw (mg/ml) (predicted, ACD/Labs)2.1
  • No.of HBond Donors0
  • No.of HBond Acceptors1
  • No.of Rotatable Bonds4
  • TPSA3.24
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA monoamine oxidase B (MAO-B) inhibitor.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)LD50=300
  • LD50 (mouse)LD50=680